Global Mechanical Thrombectomy Devices Market 2017-2021
About Mechanical Thrombectomy Devices
MIS procedures are rapidly becoming one of the leading approaches to treating various cardiovascular ailments, especially blood clots. The majority of the MIS are being performed using atherectomy and thrombectomy devices to increase the success rate of surgeries and to reduce the procedure and recovery time. Atherectomy devices are primarily used to clear blood vessels that have been occluded by fat accumulation (atherosclerosis plaque). Thrombectomy devices are used to extract, excise, or disrupt blood clots. They use a variety of methods to remove emboli in any part of the body safely.
Technavio’s analysts forecast the global Mechanical Thrombectomy Devices market to grow at a CAGR of 6.41% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global mechanical thrombectomy devices market for 2017-2021. To calculate the market size, the report considers the sales, volume, and value of global mechanical thrombectomy devices market.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Mechanical Thrombectomy Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global mechanical thrombectomy devices market: Boston Scientific, Medtronic, and Teleflex.
Other Prominent Vendors in the market are: Abbott, Acandis, AngioDynamics, Argon Medical Devices, Edwards Lifesciences, Minnetronix, NexGen Medical Systems, Penumbra, Stryker, and VASCULAR SOLUTIONS.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is increasing demand for MIS. With the advent of MIS, the patient pool is opting for them. They have proven to be better in terms of pain management and recovery time in comparison with conventional surgery. MIS can be performed for medical conditions such as stroke, DVT, and PE. The market potential for MI devices and surgeries is very high, despite the cost pressure. The scope for product innovation is higher in the MIS device market. The adoption of MIS devices is slower, yet is expected to take over the market with the increased awareness among patients.”
According to the report, one of the major drivers for this market is abdominal aortic aneurysm (AAA). One of the cardiovascular diseases is AAA, which is a heart condition that is caused by the swelling of aorta due to the weakening of the aortic wall. If left untreated, approximately one-third of the aortic wall will rupture, resulting in death in 75%-90% of the overall patient pool. Approximately 2 million people in the US suffer from aortic aneurysms, out of which only 20% cases are treated. According to the CDC, in 2015, AAA had caused 9,863 deaths in 2014.
Further, the report states that one of the major factors hindering the growth of this market is lack of product differentiation. Vendors are currently finding it difficult to remain competitive in the market because of the lack of product differentiation. Since the features and functionalities of various products are similar in nature, most of the healthcare centers and surgeons tend to opt for products based on familiarity with a specific brand name. Hence, it is critical for manufacturers to develop a technologically-advanced product line to achieve product differentiation.
Boston Scientific, Medtronic, Teleflex, Abbott, Acandis, AngioDynamics, Argon Medical Devices, Edwards Lifesciences, Minnetronix, NexGen Medical Systems, Penumbra, Stryker, and VASCULAR SOLUTIONS.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook